Zobrazeno 1 - 10
of 296
pro vyhledávání: '"Df, Stroncek"'
Publikováno v:
Blood. 81:1947-1959
In this study, we investigated the psychosocial effects of unrelated marrow donation. Survey questionnaires were administered pre-donation, shortly post-donation, and 1 year post-donation to all donors through the National Marrow Donor Program over a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bbca52c16a5ed4e9c3a746edf268cecc
https://doi.org/10.1182/blood.v81.7.1947.bloodjournal8171947
https://doi.org/10.1182/blood.v81.7.1947.bloodjournal8171947
Publikováno v:
Blood. 77:1572-1580
Antibodies to the neutrophil-specific antigens NA1 and NA2 are associated with alloimmune neonatal neutropenia (ANN), autoimmune neutropenia of childhood, and acute pulmonary transfusion reactions. These antigens have been found to be located on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1860fd713b1bec1beb2a7f799341c832
https://doi.org/10.1182/blood.v77.7.1572.bloodjournal7771572
https://doi.org/10.1182/blood.v77.7.1572.bloodjournal7771572
Autor:
Cb, Whitley, Rs, Mcivor, El, Aronovich, Susan Berry, Br, Blazar, Sr, Burger, Jh, Kersey, Ra, King, Aj, Faras, Re, Latchaw, Mccullough, J., Pan, D., Ramsay, Norma K. C., Df, Stroncek
Publikováno v:
Experts@Minnesota
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::a060c0849375a5ba4bde5df3184607b4
https://pubmed.ncbi.nlm.nih.gov/8800749
https://pubmed.ncbi.nlm.nih.gov/8800749
Publikováno v:
Blood. 80(1)
A 23-year-old woman experienced six distinct episodes of severe combined neutropenia and thrombocytopenia. At least one of the episodes was accompanied by hemodialysis-requiring acute renal failure and fragmentation hemolysis (hemolytic uremic syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1be783e3ce84303b6d229218a07b1e7e
https://pubmed.ncbi.nlm.nih.gov/1611088
https://pubmed.ncbi.nlm.nih.gov/1611088
Publikováno v:
Blood. 75(3)
Neutrophil-specific alloantibodies and the antigens they recognize are important in clinical medicine, but little is known about the structure of these antigens. Alloimmunization to the antigen NB1 is a clinically important cause of neonatal neutrope
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86b351b7bd96316215ad75edc2b4ae01
https://pubmed.ncbi.nlm.nih.gov/2153425
https://pubmed.ncbi.nlm.nih.gov/2153425
Publikováno v:
Blood. 74:1698-1703
We characterized neutrophil autoantigens using an immunoblotting technique with antibodies obtained from patients with autoimmune neutropenia. These results were correlated with serologic characterization of the antibodies, using indirect immunofluor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9327cfc081bcc3696816afd59f5ae424
https://doi.org/10.1182/blood.v74.5.1698.1698
https://doi.org/10.1182/blood.v74.5.1698.1698
Autor:
Barisic S; Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Brahmbhatt EM; Department of Surgery, Loyola University Chicago, Chicago, Illinois, USA., Cherkasova E; Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Spear TT; Department of Surgery, Loyola University Chicago, Chicago, Illinois, USA., Savani U; Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Pierre S; Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Scurti GM; Department of Surgery, Loyola University Chicago, Chicago, Illinois, USA., Chen L; Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Igboko M; Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Nadal R; Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Zeng G; T-Cure BioScience, Sherman Oaks, California, USA., Parry G; T-Cure BioScience, Sherman Oaks, California, USA., Stroncek DF; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Highfill S; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, Maryland, USA., Dalheim AV; Department of Surgery, Loyola University Chicago, Chicago, Illinois, USA., Reger R; Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA., Nishimura MI; Department of Surgery, Loyola University Chicago, Chicago, Illinois, USA., Childs RW; Laboratory of Transplantation Immunotherapy, Cellular and Molecular Therapeutics Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland, USA childsr@nhlbi.nih.gov.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Sep 11; Vol. 12 (9). Date of Electronic Publication: 2024 Sep 11.
Autor:
Boothby AB; Department of Hematology, University of Washington, Seattle, WA., Tanner MK; Internal Medicine Residency, University of Washington, Seattle, WA., Alswied A; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD., Youngs D; Bloodworks Northwest, Seattle, WA., Bribiesca Rodriguez J; School of Medicine, University of Washington, Seattle, WA., Bikkani T; Medical Student Volunteer Program, University of Washington, Seattle, WA., Cha N; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD., Gernsheimer T; Division of Hematology/Oncology, University of Washington, Seattle, WA.; Division of Hematology/Oncology, Fred Hutchinson Cancer Center, Seattle, WA., Gimferrer I; Bloodworks Northwest, Seattle, WA., Hess JR; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA., Sokol-Hessner L; Medicine Center for Scholarship in Patient Care Quality and Safety, University of Washington, Seattle, WA., Marivada S; Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Tampa, FL., Nash MG; Division of Statistical Support, Institute of Translational Health Science, University of Washington, Seattle, WA., Flegel WA; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD., Vassallo RR; Vitalant Medical Affairs, Scottsdale, AZ., Stroncek DF; Department of Transfusion Medicine, National Institutes of Health Clinical Center, Bethesda, MD., Tsang HC; Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA., Panch SR; Division of Hematology/Oncology, University of Washington, Seattle, WA.; Division of Hematology/Oncology, Fred Hutchinson Cancer Center, Seattle, WA.
Publikováno v:
Blood advances [Blood Adv] 2024 Sep 10; Vol. 8 (17), pp. 4689-4699.
Autor:
Song HW; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Prochazkova M; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Shao L; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Traynor R; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Underwood S; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Black M; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Fellowes V; Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Shi R; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Pouzolles M; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Chou HC; Genomics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Cheuk AT; Genomics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Taylor N; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Jin P; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Somerville RP; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Stroncek DF; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA., Khan J; Genomics Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Highfill SL; Department of Transfusion Medicine, Center for Cellular Engineering, National Institutes of Health, Bethesda, MD, USA. Electronic address: steven.highfill@nih.gov.
Publikováno v:
Cytotherapy [Cytotherapy] 2024 Jul; Vol. 26 (7), pp. 757-768. Date of Electronic Publication: 2024 Mar 12.
Autor:
Underwood S; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Jin J; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Shao L; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Prochazkova M; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Shi R; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Song HW; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Jin P; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Shah NN; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD., Somerville RP; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Stroncek DF; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD., Highfill SL; Center for Cellular Engineering, Department of Transfusion Medicine, Clinical Center, National Institutes of Health, Bethesda, MD.
Publikováno v:
ImmunoHorizons [Immunohorizons] 2024 Jun 01; Vol. 8 (6), pp. 404-414.